Division of Hepatobiliary Surgery and Liver Transplantation, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Division of Infectious Diseases, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Am J Transplant. 2022 Nov;22(11):2694-2696. doi: 10.1111/ajt.17134. Epub 2022 Jul 9.
The Coronavirus Disease 2019 (COVID-19) pandemic has substantially impacted solid organ transplantation, including temporary inactivation of waitlist candidates with COVID-19 infection. We report two cases of liver transplantation (LT) in individuals with asymptomatic COVID-19 infection. The first patient is a 68-year-old female with decompensated cirrhosis complicated by worsening frailty and sarcopenia. The second patient is a 22-year-old female with acute liver failure likely secondary to drug/toxin exposure. Both patients were treated with COVID-19-directed therapies and neither patient developed symptomatic disease. These cases demonstrate that LT can be safely performed in select patients with asymptomatic COVID-19 infection at the time of transplant.
2019 年冠状病毒病(COVID-19)大流行对实体器官移植产生了重大影响,包括暂时使 COVID-19 感染者的候补名单候选人失去资格。我们报告了两例 COVID-19 感染无症状患者的肝移植(LT)。第一例患者是一位 68 岁的女性,患有失代偿性肝硬化,伴有虚弱和肌肉减少症恶化。第二例患者是一位 22 岁的女性,患有急性肝功能衰竭,可能与药物/毒素暴露有关。两名患者均接受了 COVID-19 靶向治疗,且均未出现症状性疾病。这些病例表明,在移植时,选择无症状 COVID-19 感染的特定患者可以安全地进行 LT。